These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14643358)

  • 21. Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of terminal unsaturation in the side chain.
    Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Bioorg Med Chem Lett; 2001 Feb; 11(3):391-3. PubMed ID: 11212118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains.
    Maslen HL; Hughes D; Hursthouse M; De Clercq E; Balzarini J; Simons C
    J Med Chem; 2004 Oct; 47(22):5482-91. PubMed ID: 15481985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus.
    McGuigan C; Pathirana RN; Migliore M; Adak R; Luoni G; Jones AT; Díez-Torrubia A; Camarasa MJ; Velázquez S; Henson G; Verbeken E; Sienaert R; Naesens L; Snoeck R; Andrei G; Balzarini J
    J Antimicrob Chemother; 2007 Dec; 60(6):1316-30. PubMed ID: 17956908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bicyclic furo pyrimidine nucleosides with aryloxyphenyl and halophenyl substituted side chains as potent and selective varicella-zoster virus inhibitors.
    Blewett S; McGuigan C; Barucki H; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1063-6. PubMed ID: 11562959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62.
    Majima R; Shindoh K; Yamaguchi T; Inoue N
    Antiviral Res; 2017 Apr; 140():142-150. PubMed ID: 28161581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bicyclic nucleoside inhibitors of varicella-zoster virus: effect of terminal aryl substitution in the side-chain.
    Carangio A; Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2002 Sep; 13(5):263-71. PubMed ID: 12630674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain.
    McGuigan C; Barucki H; Carangio A; Blewett S; Andrei G; Snoeck R; De Clercq E; Balzarini J; Erichsen JT
    J Med Chem; 2000 Dec; 43(26):4993-7. PubMed ID: 11150169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II.
    Véron JB; Allouchi H; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
    Bioorg Med Chem; 2008 Nov; 16(21):9536-45. PubMed ID: 18835175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and screening of bicyclic carbohydrate-based compounds: a novel type of antivirals.
    Van Hoof S; Ruttens B; Hubrecht I; Smans G; Blom P; Sas B; Van hemel J; Vandenkerckhove J; Van der Eycken J
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1495-8. PubMed ID: 16403628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro evaluation of novel anti-varicella-zoster virus (VZV) nucleosides.
    Carangio A; McGuigan C; Cahard D; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):653-6. PubMed ID: 11563084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one base and nucleoside derivatives.
    Robins MJ; Miranda K; Rajwanshi VK; Peterson MA; Andrei G; Snoeck R; De Clercq E; Balzarini J
    J Med Chem; 2006 Jan; 49(1):391-8. PubMed ID: 16392824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of an 123I-labeled bicyclic nucleoside analogue (BCNA) as potential SPECT tracer for VZV-tk reporter gene imaging.
    Chitneni SK; Deroose CM; Fonge H; Gijsbers R; Dyubankova N; Balzarini J; Debyser Z; Mortelmans L; Verbruggen AM; Bormans GM
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3458-62. PubMed ID: 17446073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of N- and O-alkylated bicyclic furanopyrimidines as non-nucleosidic inhibitors of human cytomegalovirus.
    Kelleher MR; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):639-41. PubMed ID: 16248003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
    De Castro S; García-Aparicio C; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2009 Mar; 52(6):1582-91. PubMed ID: 19226140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base.
    McGuigan C; Yarnold CJ; Jones G; Velázquez S; Barucki H; Brancale A; Andrei G; Snoeck R; De Clercq E; Balzarini J
    J Med Chem; 1999 Nov; 42(22):4479-84. PubMed ID: 10579812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus.
    Baszczyňski O; Kaiser MM; Česnek M; Břehová P; Jansa P; Procházková E; Dračínský M; Snoeck R; Andrei G; Janeba Z
    Antivir Chem Chemother; 2018; 26():2040206618813050. PubMed ID: 30497281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antiherpesvirus activities of 5-alkyl-2-thiopyrimidine nucleoside analogues.
    Shigeta S; Mori S; Watanabe F; Takahashi K; Nagata T; Koike N; Wakayama T; Saneyoshi M
    Antivir Chem Chemother; 2002 Mar; 13(2):67-82. PubMed ID: 12238531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Furano pyrimidines as novel potent and selective anti-VZV agents.
    McGuigan C; Brancale A; Barucki H; Srinivasan S; Jones G; Pathirana R; Carangio A; Blewett S; Luoni G; Bidet O; Jukes A; Jarvis C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2001 Mar; 12(2):77-89. PubMed ID: 11527045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of a terminal halogen substitution in the side-chain.
    Brancale A; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1215-7. PubMed ID: 10866384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of acyclic 3-[(2-hydroxyethoxy)methyl] analogues of antiviral furo- and pyrrolo[2,3-d]pyrimidine nucleosides.
    Janeba Z; Balzarini J; Andrei G; Snoeck R; De Clercq E; Robins MJ
    J Med Chem; 2005 Jul; 48(14):4690-6. PubMed ID: 16000005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.